PlexBio Co., Ltd. (TPEX:6572)

PlexBio Statistics

Total Valuation

PlexBio has a market cap or net worth of TWD 1.04 billion. The enterprise value is 631.82 million.

Market Cap	1.04B
Enterprise Value	631.82M

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

PlexBio has 103.65 million shares outstanding.

Current Share Class	103.65M
Shares Outstanding	103.65M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	16.28%
Owned by Institutions (%)	1.01%
Float	39.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.13
PB Ratio	2.78
P/TBV Ratio	2.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.25
EV / Sales	4.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-73.10

Financial Position

The company has a current ratio of 3.18, with a Debt / Equity ratio of 0.02.

Current Ratio	3.18
Quick Ratio	2.52
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.66
Interest Coverage	-484.93

Financial Efficiency

Return on equity (ROE) is -15.43% and return on invested capital (ROIC) is -12.19%.

Return on Equity (ROE)	-15.43%
Return on Assets (ROA)	-9.13%
Return on Invested Capital (ROIC)	-12.19%
Return on Capital Employed (ROCE)	-19.71%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.24
Inventory Turnover	1.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.23% in the last 52 weeks. The beta is 0.09, so PlexBio's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	-12.23%
50-Day Moving Average	10.45
200-Day Moving Average	11.07
Relative Strength Index (RSI)	45.72
Average Volume (20 Days)	34,657

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PlexBio had revenue of TWD 128.06 million and -61.63 million in losses. Loss per share was -0.59.

Revenue	128.06M
Gross Profit	49.26M
Operating Income	-79.53M
Pretax Income	-61.63M
Net Income	-61.63M
EBITDA	-69.67M
EBIT	-79.53M
Loss Per Share	-0.59

Balance Sheet

The company has 415.53 million in cash and 5.67 million in debt, giving a net cash position of 409.86 million or 3.95 per share.

Cash & Cash Equivalents	415.53M
Total Debt	5.67M
Net Cash	409.86M
Net Cash Per Share	3.95
Equity (Book Value)	374.41M
Book Value Per Share	3.61
Working Capital	367.41M

Cash Flow

In the last 12 months, operating cash flow was -5.06 million and capital expenditures -3.59 million, giving a free cash flow of -8.64 million.

Operating Cash Flow	-5.06M
Capital Expenditures	-3.59M
Free Cash Flow	-8.64M
FCF Per Share	-0.08

Margins

Gross margin is 38.46%, with operating and profit margins of -62.10% and -48.13%.

Gross Margin	38.46%
Operating Margin	-62.10%
Pretax Margin	-48.13%
Profit Margin	-48.13%
EBITDA Margin	-54.40%
EBIT Margin	-62.10%
FCF Margin	n/a

Dividends & Yields

PlexBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-5.92%
FCF Yield	-0.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PlexBio has an Altman Z-Score of 1.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.36
Piotroski F-Score	2